// company-profile

Eagle Pharmaceuticals, Inc.

EGRX
SectorPharmaceutical PreparationsInc.DEFilings13Insiders3
// api This Eagle Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for EGRX in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Eagle Pharmaceuticals, Inc. as of 2026-03-31

— stable
Total reported AUM
$4,212
QoQ change
Reporting period
2026-03-31
#1
Stanley-Laman Group, Ltd.
CIK 1601489
$4,093
12K shares
#2
Archer Investment Corp
CIK 1803804
$119
350 shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Feb 28, 2024Tarriff ScottEGRX
Tax Withholding
2,119$6.27$13K
Feb 27, 2024Cahill Brian JosephEGRX
Award
3,800$0.00$0K
Feb 27, 2024Tarriff ScottEGRX
Award
12,950
Feb 27, 2024Tarriff ScottEGRX
Tax Withholding
3,154$6.44$20K
Feb 27, 2024Cahill Brian JosephEGRX
Tax Withholding
1,589$6.44$10K

18 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.